Skip to main content
. 2022 Mar 5;14(3):576. doi: 10.3390/pharmaceutics14030576

Figure 13.

Figure 13

Ameliorative effect of different treatments on hippocampal intraneuronal beta amyloid immunohistochemical levels in pyramidal neurons. (A) Normal controls, (B) AD model samples, (C) LUT suspension samples, and (D) LUT-BL samples. Results were expressed as mean ± SD. * Statistically significant difference from normal control group, ** statistically significant difference from the SAD model group, and # statistically significant difference from LUT suspension group.